Update on lymphadenectomy in early and advanced ovarian cancer

Current Opinion in Obstetrics & Gynecology
Roberto AngioliPierluigi Benedetti Panici

Abstract

Pelvic and para-aortic lymphnode sampling is an integral part of the staging system of ovarian cancer. The issue concerning lymphadenectomy in the management of the disease is still debated, however. The purpose of this paper is to review the role of systematic lymphadenectomy in patients affected by early and advanced-stage ovarian cancer. Some retrospective studies have revealed an increased survival rate in early-stage ovarian cancer patients after lymphadenectomy. Recently, the first randomized prospective trial, on lymphadenectomy in advanced-stage disease, was published. It evidenced an improvement in progression-free survival in patients who had undergone lymphadenectomy. Systematic lymphadenectomy has a diagnostic value in early-stage ovarian cancer, thanks to the possibility of accurate clinical staging. As up to 22% of women, who were presumed to have early-stage ovarian cancers, are upstaged during the lymphadenectomy procedure, accurate staging can help to avoid unnecessary postoperative chemotherapy. In patients affected by advanced ovarian cancer, systematic lymphadenectomy statistically significantly improves progression-free survival and reduces recurrence rates despite a higher incidence of postoperative compli...Continue Reading

References

Oct 1, 1992·Gynecologic Oncology·J M ChildersE A Surwit
Feb 1, 1991·American Journal of Obstetrics and Gynecology·D QuerleuB Castelain
Feb 1, 1991·Gynecologic Oncology·E BurghardtH Stettner
Nov 1, 1986·American Journal of Obstetrics and Gynecology·P C WuL J Lian
Jul 1, 1983·Journal of Dental Research·D F Averette, M Marek
Feb 1, 1994·American Journal of Obstetrics and Gynecology·E PetruR Winter
Nov 1, 1993·Gynecologic Oncology·P Benedetti-PaniciS Mancuso
Nov 5, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·Pierluigi Benedetti Panici, Roberto Angioli
Aug 2, 2003·Journal of the American College of Surgeons·Philippe MoriceDamienne Castaigne
Aug 23, 2005·Gynecologic Oncology·Nobuhiro TakeshimaKatsuhiko Hasumi
Jan 2, 2007·Obstetrics and Gynecology·John K ChanKathryn Osann
Feb 27, 2007·Gynecologic Oncology·Augusto PereiraPaul M Magtibay

❮ Previous
Next ❯

Citations

Apr 7, 2010·Journal of Clinical Pathology·Roland SeilerAchim Fleischmann
Oct 27, 2009·Annals of Surgical Oncology·Dario BarattiMarcello Deraco
Apr 29, 2009·The Tohoku Journal of Experimental Medicine·Yong Man KimJoo Hyun Nam
Oct 16, 2013·Molecular Medicine Reports·Yong-Wen HuangXin Huang
Oct 5, 2010·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Yu-Jin KooJung-Eun Mok
Jan 23, 2014·Acta Obstetricia Et Gynecologica Scandinavica·Olivia SvolgaardClaus Høgdall
Dec 26, 2012·Gynecologic Oncology·Ganna ChornokurCatherine M Phelan
Aug 29, 2016·American Journal of Obstetrics and Gynecology·Alexander MelamedJ Alejandro Rauh-Hain
Apr 24, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Minna M MäenpääJohanna U Mäenpää
Sep 24, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Marjolein KleppeMarco C DeRuiter
Mar 26, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Reita H NybergJohanna Mäenpää
Oct 22, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Marjolein KleppeRoy F P M Kruitwagen
Jan 7, 2009·Current Opinion in Obstetrics & Gynecology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.